recombinant human erythropoietin
Recently, it was reported that blood vessel immunoreactive endothelin-1 (irET-1)        content is increased in hypertensive uremic rats treated with recombinant human       erythropoietin (rhEPO).
Recently, it was reported that blood vessel immunoreactive endothelin-1 (irET-1)        content is increased in hypertensive uremic  @OBJECT$   @PREDICAT$  with  @SUBJECT$  (rhEPO).